| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10962641 | Vaccine | 2016 | 4 Pages |
Abstract
PCV13 VE against the extra six serotypes with the 3Â +Â 1 schedule in Germany was only marginally higher compared to previously published data for the 2Â +Â 1 schedule.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Raphael Weinberger, Mark van der Linden, Matthias Imöhl, Rüdiger von Kries,